# Gegnum

> Gegnum is a VC fund in São João Da Madeira backing Medical, Life Science and Biotechnology. See 1 investments, check sizes, portfolio. Updated Oct 2026.

- Type: VC Fund
- Location: São João Da Madeira, Portugal
- Total investments: 1
- Last investment: Mar 2015
- Lead investor: 0%
- Last updated: Oct 2026

Gegnum is a VC fund in São João Da Madeira focused on Medical and Life Science. Gegnum - Gestão e Investimentos, Lda. is a company based in São João da Madeira, Portugal.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| Life Science | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |
| Health Diagnostics | 1 | 100% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Biomode | Biomode is a startup venture based in Caldas das Taipas (Portugal) that aims to be a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens in the food, environment and life science industries.Biomode’s diagnostic kits are based on the PNA-FISH (Peptide Nucleic Acid Fluorescence In Situ Hybridisation)technology.Biomode’s founders are a group of researchers from the universities of Minho and Porto (Portugal) that is one of the few worldwide research groups with the skills to design PNA-FISH probes targeting specific pathogens.Biomode will enter the food industry diagnostics market with a kit for detecting Salmonella in food samples (Probe4Salmonella®) soon to be followed by two other kits for the detection of Listeria monocytogenes and E. coli O157:H7. On the clinical diagnostics area, Biomode has already developed a kit aimed at the rapid identification of clarithromycin resistance of H. Pylori strains (Probe4Pylori®) that is in the process of obtaining investigational device exemption from the Food and Drug Administration (FDA) in order to undergo field trials. | $1.7M | Series A | Mar 19, 2015 | http://www.biomode-sa.com |

1 of 1 investments shown.

## Co-investors
- [2bpartner Sociedade de Capital de Risco S.A.](https://shizune.co/investors/profile/2bpartner) — VC Fund, 1 deal together
- [ChangePartners](https://shizune.co/investors/profile/changepartners) — VC Fund, 1 deal together
- [Invicta Angels](https://shizune.co/investors/profile/invicta-angels) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Portugal Ventures](https://shizune.co/investors/profile/portugal-ventures) — VC Fund
- [Caixa Capital](https://shizune.co/investors/profile/caixa-capital-2) — VC Fund
- [Shilling VC](https://shizune.co/investors/profile/shilling-capital-partners) — VC Fund

## Featured in investor lists
- [Biotech Investors in Portugal](https://shizune.co/investors/biotech-investors-portugal)
- [Biotech VC Funds in Portugal](https://shizune.co/investors/biotech-vc-funds-portugal)

## FAQ

### What does Gegnum invest in?

Gegnum invests primarily in Medical, Life Science and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Portugal. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Gegnum last invest?

The most recent investment recorded for Gegnum closed in Mar 2015. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co